Simulated Value-Based Insurance Design Applied to Statin Use by Medicare Beneficiaries with Diabetes

Reducing statin co-payments for Medicare beneficiaries with diabetes resulted in modestly increased use and reduced medical spending. The value-based insurance design simulation strategy met financial feasibility criteria but only for higher-risk patients.